Literature DB >> 1515750

A 10-year prognosis for childhood allergic rhinitis.

O Linna1, J Kokkonen, M Lukin.   

Abstract

The prognosis of allergic rhinitis was studied in 154 children aged 3-17 years at diagnosis by means of a detailed questionnaire administered 8-11 years later. The symptoms had completely disappeared in only 15 (10%) patients. The conjunctival symptoms, however, had disappeared or were controlled successfully by topical drug therapy in almost all, and 77 (50%) were managing without medication for allergic rhinitis. Twenty-five (23%) of the 110 children with seasonal allergic rhinitis had a perennial disease at follow-up, in contrast to seven (16%) of 44 with perennial allergic rhinitis originally who had only seasonal symptoms at follow-up. Asthma or wheezing had developed in 29 cases (19%) and was more common (p less than 0.01) among those with perennial allergic rhinitis (15 of 44) than among those with seasonal allergic rhinitis (14 of 110). No significant association was found between age at onset of symptoms, family history of atopic disease or type of treatment for allergic rhinitis and allergic rhinitis still present at follow-up or development of asthma during the observation period.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1515750     DOI: 10.1111/j.1651-2227.1992.tb12182.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  8 in total

Review 1.  Epidemiology of allergic rhinitis.

Authors:  R Michael Sly
Journal:  Clin Rev Allergy Immunol       Date:  2002-02       Impact factor: 8.667

Review 2.  Pollen immunotherapy: selection,prevention, and future directions.

Authors:  Steven J McEldowney; Robert K Bush
Journal:  Curr Allergy Asthma Rep       Date:  2006-09       Impact factor: 4.806

3.  Hay fever, eczema, and wheeze: a nationwide UK study (ISAAC, international study of asthma and allergies in childhood).

Authors:  J B Austin; B Kaur; H R Anderson; M Burr; L S Harkins; D P Strachan; J O Warner
Journal:  Arch Dis Child       Date:  1999-09       Impact factor: 3.791

Review 4.  Immunotherapy for rhinitis.

Authors:  Hans-Jørgen Malling
Journal:  Curr Allergy Asthma Rep       Date:  2003-05       Impact factor: 4.919

5.  Changes in Peak Flow value during immunotherapy administration.

Authors:  Diego Saporta
Journal:  J Environ Public Health       Date:  2012-02-07

6.  Allergic sensitization to perennial allergens in adults and children sensitized to Japanese cedar or Japanese cypress pollen in Japan.

Authors:  Masafumi Ohki; Masanobu Shinogami
Journal:  Int J Otolaryngol       Date:  2014-03-17

7.  New treatment options in allergic rhinitis: patient considerations and the role of ciclesonide.

Authors:  F Braido; C Lagasio; Img Piroddi; I Baiardini; Gw Canonica
Journal:  Ther Clin Risk Manag       Date:  2008-04       Impact factor: 2.423

Review 8.  Sublingual Immunotherapy: A Useful Tool for the Allergist in Private Practice.

Authors:  Diego Saporta
Journal:  Biomed Res Int       Date:  2016-05-31       Impact factor: 3.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.